Table 2.
rRgpAH, RgpB, and rKgp activity fold changes with cysteine addition in the presence or absence of glycylglycine.
| Additives | Concentrations used (mM) | Fold activity change with additives | ||
|---|---|---|---|---|
| rRgpAH | RgpB | rKgp | ||
|
Cysteine Glycylglycine |
0 or 20 0 |
5.2 | 5.1 | 5.6 |
|
Cysteine Glycylglycine |
0 or 200 0 |
10 | 9 | 11.8 |
|
Cysteine Glycylglycine |
20 or 200 0 |
1.9 | 1.8 | 2.2 |
|
Cysteine Glycylglycine |
0 300 (Arg), 180 (Lys) |
10.8 | 5.7 | 12.8 |
|
Cysteine Glycylglycine |
0 or 20 300 (Arg), 180 (Lys) |
3.2 | 3.1 | 2.3 |
|
Cysteine Glycylglycine |
0 or 20 0 or 300 (Arg), 0 or 180 (Lys) |
34 | 17.6 | 29.5 |
|
Cysteine Glycylglycine |
20 or 200 300 (Arg), 180 (Lys) |
30 | 16.2 | 28.5 |